Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Guodi Liu"'
Publikováno v:
mAbs, Vol 15, Iss 1 (2023)
ABSTRACTAntibody-based immune checkpoint blockade (ICB)-based therapeutics have become effective clinical applications for cancers. Applications of monoclonal antibodies (mAbs) to de-activate the PD-1-PD-L1 pathway could effectively reverse the pheno
Externí odkaz:
https://doaj.org/article/2d2522248ef648fd90bc155223e64b00
Autor:
Qian Zhang, Zhiqiang Zhang, Guodi Liu, Dehua Li, Zhangjie Gu, Linsong Zhang, Yingjiao Pan, Xingbing Cui, Lu Wang, Guoping Liu, Xiaoli Tian, Ziming Zhang
Publikováno v:
BMC Cancer, Vol 22, Iss 1, Pp 1-12 (2022)
Abstract Background Osteosarcoma (OS) mainly happens in children and youths. Surgery, radiotherapy and chemotherapy are the common therapies for osteosarcoma treatment but all their anti-tumor effects are limited. In recent years, a new cellular ther
Externí odkaz:
https://doaj.org/article/2db7c1a9d45d421d8e2e9e5f4c816f70
Autor:
Qian Zhang, Guoping Liu, Jibin Liu, Mu Yang, Juan Fu, Guodi Liu, Dehua Li, Zhangjie Gu, Linsong Zhang, Yingjiao Pan, Xingbing Cui, Lu Wang, Lixin Zhang, Xiaoli Tian
Publikováno v:
Molecular Therapy: Oncolytics, Vol 20, Iss , Pp 556-568 (2021)
Since the approval of chimeric antigen receptor (CAR) T cell therapy targeting CD19 by the FDA, CAR-T cell therapy has received increasing attention as a new method for targeting tumors. Although CAR-T cell therapy has a good effect against hematolog
Externí odkaz:
https://doaj.org/article/1cfe4433d1244839926c526b5e415616
Publikováno v:
Immunology Letters. 255:1-9
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f78544baf2109b2598b116f799b111f
https://doi.org/10.1016/j.imlet.2023.01.011
https://doi.org/10.1016/j.imlet.2023.01.011
Autor:
Yu Han, Xue Bai, Siying Liu, Jingfei Zhu, Fan Zhang, Lifen Xie, Guodi Liu, Xiaohui Jiang, Mingchao Zhang, Yingkang Huang, Jingfeng Wang, Dapei Li, Huiying Zhang, Yuanqing He, Sudan He, Yu Xia, Xiulong Xu, Feng Xu, Feng Ma
Publikováno v:
Journal of Virology. 96
XIAP-associated factor 1 (XAF1) is an interferon (IFN)-stimulated gene (ISG) that enhances IFN-induced apoptosis. However, it is unexplored whether XAF1 is essential for the host fighting against invaded viruses. Here, we find that XAF1 is significan
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f329b016d6fb5def71ed3ef5f151c3ff
https://doi.org/10.1128/jvi.00774-22
https://doi.org/10.1128/jvi.00774-22
Autor:
Mu Yang, Qian Zhang, Jibin Liu, Zhangjie Gu, Guodi Liu, Yingjiao Pan, Dehua Li, Xiaoli Tian, Xingbing Cui, Guoping Liu, Jinwei Gu, Linsong Zhang
Publikováno v:
Human Immunology. 82:130-138
Chimeric antigen receptor T (CAR T) cell therapy is a new pillar in cancer therapeutics, and has been successfully used for the treatment of cancers, including acute lymphoblastic leukemia and solid cancers. Following immune attack, many tumors upreg
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3365f3bb63f34a7acc97cba8b654fbbd
https://doi.org/10.1016/j.humimm.2020.12.002
https://doi.org/10.1016/j.humimm.2020.12.002
Publikováno v:
The Journal of Veterinary Medical Science
Ovarian cancer (OC) is one of the most lethal solid tumors with poor prognosis. In 2017, two chimeric antigen receptor-T (CAR-T) cell drugs were approved by the U.S. Food and Drug Administration (FDA), and continuously optimized CAR-T cells therapy m
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b1d388871390ab3da61ad35a9677ac7b
https://doi.org/10.1292/jvms.20-0455
https://doi.org/10.1292/jvms.20-0455
Autor:
Yu Han, Jing Zhu, Xue Bai, Siying Liu, Fan Zhang, Guodi Liu, Mingchao Zhang, Yingkang Huang, Jingfeng Wang, Dapei Li, Haiping Yao, Huiying Zhang, Xiaohui Jiang, Zhengrong Chen, Yongdong Yan, Yu Xia, Ping Xu, Xiulong Xu, Feng Xu, Feng Ma
Publikováno v:
SSRN Electronic Journal.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a9a5f4857b3ae12e50c9b9cd34f815e
https://doi.org/10.2139/ssrn.4057119
https://doi.org/10.2139/ssrn.4057119
Autor:
Qian Zhang, Mu Yang, Linsong Zhang, Peizi He, Zhangjie Gu, Guodi Liu, Yingjiao Pan, Jibin Liu, Xingbing Cui, Guoping Liu, Xiaoli Tian, Xiang Li, Dehua Li
Publikováno v:
Journal of pharmaceutical and biomedical analysis. 198
Among the many systems available for heterologous protein production gram-negative bacterium Escherichia coli (E. coli) has long been widely used because of its ability to grow rapidly with a high density on inexpensive substrates. The use of E. coli
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::94181919c6f29600b8d672db90f0d810
https://pubmed.ncbi.nlm.nih.gov/33706144
https://pubmed.ncbi.nlm.nih.gov/33706144
Autor:
Huixin Tian, Dehua Li, Xiaoli Tian, Qian Zhang, Guoping Liu, Linsong Zhang, Zhangjie Gu, Guodi Liu, Yong Zhang
Publikováno v:
Experimental Cell Research. 409:112886
Chimeric antigen receptor (CAR) T cells have been successfully used for the treatment of hematological malignancies including acute and chronic lymphoblastic leukemia. However, results of CAR T cell projects in solid tumors have been less impressive
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fe8184e1ec5c4f7619c0a074afca1e46
https://doi.org/10.1016/j.yexcr.2021.112886
https://doi.org/10.1016/j.yexcr.2021.112886